Status:
UNKNOWN
Management of Warthin Tumor of Parotid Gland.
Lead Sponsor:
Assiut University
Conditions:
Warthin's Tumor of Parotid Gland
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Comparison between Ultrasound-Guided Ethanol Sclerotherapy (UGES) \& surgical excision in management of warthin tumor of parotid gland.
Detailed Description
Warthin tumor (also known as cystadenolymphoma), is a benign and frequent salivary gland neoplasm. It represents about 2% to 15% of all primary epithelial tumors of the parotid gland. Warthin tumor ...
Eligibility Criteria
Inclusion
- All new cases presented with benign parotid cyst and diagnosed as Warthin tumour in the parotid gland.
Exclusion
- Other Parotid gland tumours e.g. solid tumours, malignant tumours and other suspicious tumours.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05221736
Start Date
May 1 2022
End Date
October 31 2023
Last Update
February 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university
Asyut, Egypt